19 May 2013
Keywords: ordered, pay, amgen, costs, procrit, case, biotechnology
Article | 03 February 2003
US biotechnology major Amgen says that an arbitrator has determined thatthe firm was the prevailing party in the recent arbitration ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 February 2003
27 January 2003
17 May 2013
© 2013 thepharmaletter.com